All companies
Visit website
RedOak Instruments, LLC
OperatingFounded 2008
Red Oak Instruments produces biomedical devices that allow quantitative measurements of fine motor skills and provides doctors and physicians with new ways to measure a patient’s functionality, aiding them in their diagnosis. Why Guess? Measure.
Post-money valuation ⓘ
$7.0M
As of Apr 2021 · from RedOak Instruments, LLC Stock 1 · pre-money + amount raised, not a traded price
Total raised
$47,080
Across 1 round since 2021
Latest share price
$2.00
RedOak Instruments, LLC Stock 1 offering price
Financials
FY2018–FY2021 · from SEC filings · hover any figure for its source$0
−$277K
2018
$0
−$243K
2019
$0
−$185K
2020
$0
−$49K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$75,389
$0
$0
$0
Net income
-$276,797
-$243,003
-$184,698
-$48,716
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$126,565
$17,987
$1,882
$9,098
Accounts receivable
$0
$0
$0
$0
Total assets
$180,467
$70,738
$68,636
$75,852
Short-term debt
$4,983
$257
$0
$0
Long-term debt
$0
$0
$0
$0
Total liabilities
$4,983
$257
$0
$0
Other
Headcount
—
0
—
0
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$7.0M
post-money
RedOak Instruments, LLC Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $47.1K / $1MPost-money $7M
Reg CF annual-report compliance
Possibly delinquent
Filed 1 of 6 annual reports (FY2020–FY2025)
Missing: 2020, 2022, 2023, 2024, 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001836234Share price $2.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.